Publicaties WCN-studies: dr. A.M.W. Alings

• Effects of a stepwise, structured LDL-C lowering strategy in patients post-acute coronary syndromeNetherlands Heart Journal - Abstract - Alings, dr. A.M.W.; Liem, dr. A.H.; Groenemeijer, dr. B.E.; Schut, drs. A. - PENELOPE - ASCVD January 2024
• Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation J.S. Healey, R.D. Lopes, C.B. Granger, M. Alings, L. Rivard, W.F. McIntT h e n e w e ngl a nd j o u r na l o f m e dic i n e - Alings, dr. A.M.W. - ARTESiA - Arrhythmia November 2023
• Direct Oral Anticoagulants for Stroke Prevention in Patients with Device- Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA TrialsCirculation - Alings, dr. A.M.W. - NOAH - AFNET 6 - Arrhythmia November 2023
• Self-administered intranasal etripamil using a symptom- prompted, repeat-dose regimen for atrioventricular-nodal- dependent supraventricular tachycardia (RAPID): a multicentre, randomised trialLancet - Alings, dr. A.M.W.; Houtgraaf, J. - NODE-301 part 2 (RAPID) - Arrhythmia June 2023
• Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trialEur Heart J Cardiovasc Pharmacother - Abstract - Alings, dr. A.M.W. - COMPASS - ASCVD April 2022
• Colchicine in Patients with Chronic Coronary DiseaseNew England Journal of Medicine - Abstract - Mosterd, dr. A.; Fiolet, dr. A. [inactief]; The, dr. S.H.K. [inactief]; Lenderink, dr. T.; Hoogslag, drs. P.A.M.; Jerzewski, dr. A. [inactief]; Nierop, drs. P.R.; Swart, drs. H.P.; Schaap, dr. J.; Kuijper, dr. A.F.M.; Hessen, dr. M.W.J. van; Dirksen, dr. M.T.; Alings, dr. A.M.W.; Schut, drs. A.; Cornel, prof. dr. J.H. - LoDoCo2 - ASCVD August 2020
• Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial.Eur J Prev Cardiol - Abstract - Alings, dr. A.M.W. - COMPASS - ASCVD October 2019
• Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial.European Heart Journal - Abstract - Alings, dr. A.M.W. - COMPASS - ASCVD September 2019
• Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.Gastroenterology - Abstract - Alings, dr. A.M.W. - COMPASS - ASCVD September 2019
• Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled TrialGastroenterology - Abstract - Alings, dr. A.M.W. - COMPASS - ASCVD August 2019
• Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillationHeart - Abstract - Alings, dr. A.M.W. - ARISTOTLE - Arrhythmia April 2019
• Stroke Outcomes in the COMPASS TrialCirculation - Abstract - Alings, dr. A.M.W. - COMPASS; COMPASS-LTOLE - ASCVD February 2019
• Prevention of Arrhythmia Device Infection Trial - The PADIT TrialJACC - Alings, dr. A.M.W.; Hemels, dr. M.E.W.; Bouwels, drs. L.H.R. H R [inactief]; Vlies, dr. B. van [inactief] - PADIT - Arrhythmia December 2018
• Prevention of Arrhythmia Device Infection Trial: The PADIT TrialJournal of the American College of Cardiology - Abstract - Alings, dr. A.M.W.; Hemels, dr. M.E.W.; Bouwels, drs. L.H.R. H R [inactief]; Vlies, dr. B. van [inactief] - PADIT - Arrhythmia December 2018
• Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial.J Am Coll Cardiol - Abstract - Alings, dr. A.M.W. - ODYSSEY - ASCVD October 2018
• Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trialEuropean Heart Journal - Abstract - Alings, dr. A.M.W.; Tieleman, dr. R.G.; Tukkie, dr. R. - RACE III - Arrhythmia August 2018
• Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) TrialJ Am Heart Assoc - Abstract - Alings, dr. A.M.W. - ARISTOTLE - Arrhythmia February 2018
• Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial.Eur Heart J - Abstract - Alings, dr. A.M.W.; Tukkie, dr. R.; Tieleman, dr. R.G. - RACE III - Arrhythmia February 2018
• Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.Lancet - Abstract - Alings, dr. A.M.W. - COMPASS - ASCVD November 2017
• Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.Can J Cardiol - Abstract - Alings, dr. A.M.W. - COMPASS - ASCVD August 2017
• Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseN Engl J Med - Abstract - Alings, dr. A.M.W. - COMPASS - ASCVD August 2017
• Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trialAm Heart J - Abstract - Alings, dr. A.M.W. - ARTESiA - Arrhythmia July 2017
• Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialAm Heart J - Abstract - Alings, dr. A.M.W. - ARISTOTLE - Arrhythmia March 2017
• Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trialInt J Cardiol - Abstract - Alings, dr. A.M.W. - ARISTOTLE - Arrhythmia November 2016
• Individualising Anticoagulant Therapy in Atrial Fibrillation PatientsArrhythm Electrophysiol Rev - Abstract - Alings, dr. A.M.W. - ARISTOTLE; ROCKET-AF; RE-LY - Arrhythmia August 2016
• Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary-Revision 1Eur Heart J - Abstract - Alings, dr. A.M.W. - ARISTOTLE; ROCKET-AF; RE-LY - Arrhythmia June 2016
• Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial.J Thromb Haemost - Abstract - Alings, dr. A.M.W. - RE-LY - Arrhythmia May 2015
• Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.Eur Heart J - Abstract - Alings, dr. A.M.W. - ARISTOTLE - Arrhythmia May 2015
• Digoxin in patients with permanent atrial fibrillation: data from the RACE II studyHeart Rhythm - Abstract - Alings, dr. A.M.W. - RACE II - Arrhythmia September 2014
• Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trialEur Heart J - Abstract - Alings, dr. A.M.W. - ARISTOTLE - Arrhythmia January 2014
• Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study.Eur J Heart Fail - Abstract - Alings, dr. A.M.W. - RACE II - Arrhythmia November 2013
• Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial.Eur Heart J - Abstract - Alings, dr. A.M.W. - ARISTOTLE - Arrhythmia July 2013
• Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 studyNeth Heart J - Abstract - Alings, dr. A.M.W.; Willems, dr. F.F.; Tieleman, dr. R.G.; Tukkie, dr. R. - RACE III - Arrhythmia July 2013
• The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.Circulation - Abstract - Alings, dr. A.M.W. - RELY-able - Arrhythmia July 2013
• Randomized cluster crossover trials for reliable, efficient, comparative effectiveness testing: design of the Prevention of Arrhythmia Device Infection Trial (PADIT).Can J Cardiol - Abstract - Alings, dr. A.M.W. - PADIT - Arrhythmia June 2013
• EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summaryEur Heart J - Abstract - Alings, dr. A.M.W. - RE-LY; ARISTOTLE; ROCKET-AF - Arrhythmia April 2013
• Rate control in atrial fibrillation, insight into the RACE II studyNeth Heart J - Abstract - Tuininga, dr. Y.S.; Alings, dr. A.M.W. - RACE II - Arrhythmia April 2013
• Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study.Eur Heart J - Abstract - Alings, dr. A.M.W. - SHIFT - Heart failure November 2012
• Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.Lancet Neurol - Abstract - Alings, dr. A.M.W. - ARISTOTLE - Arrhythmia June 2012
• Upstream therapy in patients with early atrial fibrillation: The relevance of the Routine versus Aggressive upstream rhythm Control for prevention of Early atrial fibrillation in heart failure (RACE 3) studyNeth Heart J - Abstract - Alings, dr. A.M.W. - RACE III - Arrhythmia November 2010
• Lenient versus strict rate control in patients with atrial fibrillationN Engl J Med - Abstract - Bosker, dr. H.A. [inactief]; Alings, dr. A.M.W.; Cornel, prof. dr. J.H.; Tukkie, dr. R.; Kuijper, dr. A.F.M.; Tuininga, dr. Y.S. - RACE II - Arrhythmia April 2010
• Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndromeAm Heart J - Abstract - Hof, prof. dr. A.W. J. van 't; Alings, dr. A.M.W.; Lok, dr. D.J.A.; Liem, dr. A.H.; Kragten, dr. J.A.; Bronzwaer, drs. P.N.A. [inactief]; Cornel, prof. dr. J.H.; Freericks, M.P.; Hamer, drs. B.J.B.; Hamraoui, drs. K.; Hoedemaker, drs. G. [inactief]; Kuijper, dr. A.F.M.; Linssen, dr. G.C.M.; Louwerenburg, drs. J.W. [inactief]; Nierop, drs. P.R.; Oomen, drs. A. [inactief]; Plomp, drs. J.; Pos, drs. L.; Eck, dr. J.W.M. van; Willems, dr. F.F. - Dal-OUTCOMES - ASCVD December 2009